Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers...

Immunotherapy improves long-term overall survival in patients with advanced melanoma, according to the results of a...

The European Society for Medical Oncology (ESMO) Congress 2024, which took place from 13-17 September in...

How the cutting-edge early phase oncology trials programme, START Dublin, came about and what it strives...

Vaginal health. Emerging research suggests that probiotics, particularly strains of  Lactobacillus, may help restore and maintain...

New Irish research has revealed the first-ever national data on the incidence of sudden unexpected death...

New research presented at ECTRIMS 2024 suggests that initiating monoclonal antibody therapy during childhood, rather than...

 A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new...

A pioneering study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening...

A new study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS),...

Recent developments in the understanding of MS pathogenesis have suggested new avenues for disease-modifying therapy; in...

Attendees at UCD’s Charles Institute Seminar Series recently heard a presentation by Professor of...